No you're not. I just don't believe 145 million is a large amount. If it goes a bit higher and there's no revenue or a breakthrough then the pps will go down. I agree.
I also believe that if FUSE announces a pharma deal or comes out with aspirin or insulin drops, 200 million shares isn't going to be enough for the demand.
Don't forget, FUSE has a product selling well showcasing their transdermal technology. Shortly we will see the sublingual technology in their drops.
Think of it that way. A showcasing for the home run to come in the future. The applications have already been proven out!
News 
Market Data 
Discover 
AI
